Sign in

CIK 0001531177

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Sight Sciences, Inc.

Sign in to watch
Ticker
SGHT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
800625749
Phone
+1 415-889-0550
Business address
4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Option exercise Chief Technology Officer acquired 40,000 shares (option exercise)
  4. 4 Open-market sale Chief Legal Officer sold 9,160 shares at $4.17 ($38,234)
  5. 4 Open-market sale Chief Financial Officer sold 19,260 shares at $4.10 ($78,927)
  6. 4 Open-market sale President and CEO sold 23,637 shares at $4.15 ($98,141)
  7. 4 Open-market sale Chief Technology Officer sold 5,679 shares at $4.17 ($23,704)
  8. 4 Open-market sale Chief Commercial Officer sold 4,889 shares at $4.10 ($20,035)
  9. 4 Grant or award Director acquired 30,952 shares (grant or award)
  10. 4 Grant or award Director acquired 30,952 shares (grant or award)
  11. 4 Grant or award Director acquired 30,952 shares (grant or award)
  12. 4 Grant or award Director acquired 30,952 shares (grant or award)
  13. 4 Grant or award Director acquired 30,952 shares (grant or award)
  14. 4 Open-market buy Director bought 90,525 shares at an average $4.22 ($381,958)
  15. 4 Open-market buy Director bought 98,782 shares at an average $3.81 ($376,429)
  16. 4 Open-market buy Director bought 128,189 shares at an average $3.52 ($451,734)
  17. 4 Grant or award EVP, Research & Development acquired 12,767 shares (grant or award)
  18. 4 Open-market sale Chief Financial Officer sold 13,066 shares at $3.48 ($45,430)
  19. 4 Grant or award Chief Commercial Officer acquired 6,631 shares (grant or award)
  20. 4 Grant or award Director acquired 74,766 shares (grant or award)

Page 4 of 12 · 225 filings